Moreover, SNAI2 drives EMT in neuroblastoma cells [10], and, reciprocally, SNAI2 knockdown increases the sensitivity to apoptosis-inducing compounds and impairs the metastatic potential of neuroblastoma cells in vitro and in vivo [11]. This evidence concerns the gene SNAI2 and neuroblastoma.